Search

Your search keyword '"Mikiya Endo"' showing total 2 results
Start Over Author "Mikiya Endo" Journal bone marrow transplantation
2 results on '"Mikiya Endo"'

1. Unrelated cord blood transplantation in aplastic anemia: is anti-thymocyte globulin indispensable for conditioning?

Author

Seiji Kojima, Kazuko Kudo, S Kounami, Mikiya Endo, Masami Inoue, Junichi Hara, Ryoji Kobayashi, Koji Kato, Atsushi Narita, Jiro Inagaki, Hiromasa Yabe, Ken Tabuchi, Nao Yoshida, Hideki Muramatsu, and Yoshiko Hashii

Subjects
Male, Transplantation Conditioning, Globulin, Anemia, Cord Blood Stem Cell Transplantation, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, Medicine, Humans, Aplastic anemia, Child, Antilymphocyte Serum, Retrospective Studies, Transplantation, biology, business.industry, Anemia, Aplastic, Infant, Retrospective cohort study, Hematology, medicine.disease, Allografts, Anti-thymocyte globulin, Clinical trial, surgical procedures, operative, 030220 oncology & carcinogenesis, Child, Preschool, Immunology, biology.protein, business, Unrelated Donors, 030215 immunology, Follow-Up Studies
Abstract

Unrelated cord blood transplantation in aplastic anemia: is anti-thymocyte globulin indispensable for conditioning?

Published
2017

2. Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan

Author

Y. Hirota, Megumi Oda, T Takano, Koichiro Yamada, Shinsaku Imashuku, N. Kinugawa, Nobuyuki Miura, A. Akazai, Takeyuki Sato, A. Yamamoto, H Kakuta, and Mikiya Endo

Subjects
Male, Pediatrics, medicine.medical_specialty, medicine.medical_treatment, Hematopoietic stem cell transplantation, Japan, Langerhans cell histiocytosis, Refractory, immune system diseases, hemic and lymphatic diseases, medicine, Humans, Transplantation, Homologous, Child, Transplantation, business.industry, Septic shock, Hematopoietic Stem Cell Transplantation, Infant, Hematology, medicine.disease, Surgery, Histiocytosis, Langerhans-Cell, Histiocytosis, surgical procedures, operative, medicine.anatomical_structure, Allogeneic hsct, Bone marrow, business
Abstract

There exists limited information about the usefulness of hemopoietic stem cell transplantation (HSCT) for the treatment of patients with refractory Langerhans cell histiocytosis (LCH). We report here four Japanese pediatric patients with multisystem LCH disease who underwent HSCT between 1994 and 1997. Two of the four patients are doing well without any relapse. However, neither of them shows improved sequelae 3 to 4 years after allogeneic HSCT, although the graft was rejected in one of the cases. The remaining two patients died of septic shock. A review of the literature of 11 patients revealed four fatalities after the use of HSCT in the treatment of LCH. Three of these were due to active LCH and three deaths occurred within 2 months after HSCT. To establish the usefulness of HSCT for refractory LCH, further studies are required.

Published
1999
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results